Cyberounds Logo
August 03, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
The Genetics of Colon Carcinoma
CME credit is no longer available for this conference.
Maulik Shah, M.D., Ph.D. and Priya Gopalan, M.D., Ph.D.

Dr. Shah, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX. Dr Gopalan, Department of Obstetrics and Gynecology, Washington University, St. Louis, MO.

Drs. Shah and Gopalan report no commercial conflicts of interest.

Release Date: 04/25/2001
Termination Date: 04/25/2004

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the molecular pathogenesis of sporadic vs. hereditary colorectal cancer
  • Describe the rare hereditary syndromes and the more common hereditary nonpolyposis colon cancer (HNPCC)
  • Diagnose HNPCC by Bethesda Criteria
  • List screening and management guidelines for HNPCC.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity